Oncology

  1. Lynparza (olaparib)
    Lynparza (olaparib)
    by AstraZeneca AB
    for Breast Cancer, Gynaecological Cancer
    €6,283.20
  2. Ninlaro (ixazomib)
    Ninlaro (ixazomib)
    by Takeda Pharma A/S
    for Multiple Myeloma
    €6,558.60
  3. Odomzo (sonidegib)
    Odomzo (sonidegib)
    by Sun Pharmaceutical Industries Europe B.V.
    for Skin Cancer
    €5,642.40
  4. Onivyde (irinotecan hydrochloride trihydrate)
    Onivyde (irinotecan hydrochloride trihydrate)
    by Baxalta Innovations GmbH
    for Pancreatic Cancer
    €1,125.60
  5. Opdivo (nivolumab)
    Opdivo (nivolumab)
    by Bristol-Myers Squibb Pharma EEIG
    for Urothelial Carcinoma, Colorectal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Skin Cancer
    €497.04
  6. Perjeta (pertuzumab)
    Perjeta (pertuzumab)
    by Roche Registration Limited
    for Breast Cancer
    €2,988.60
  7. Portrazza (necitumumab)
    Portrazza (necitumumab)
    by Eli Lilly Nederland B.V.
    for Lung Cancer
    €622.80
  8. Rubraca (rucaparib)
    Rubraca (rucaparib)
    by Clovis Oncology, Inc.
    for Gynaecological Cancer
    €4,970.00
  9. Rydapt (midostaurin)
    Rydapt (midostaurin)
    by Novartis Europharm Limited
    for Leukemia
    €16,310.40
View as Grid List

Items 28-36 of 39

per page
Set Descending Direction